{
    "Trade/Device Name(s)": [
        "QuickVue Influenza A+B",
        "QuickVue\u00ae Influenza A+B test"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K092698",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031899",
        "K053146"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "September 15, 2009",
    "Summary Letter Received Date": "September 2, 2009",
    "Submission Date": "September 1, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza type A antigen",
        "Influenza type B antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal aspirate",
        "Nasal wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral-flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral-flow"
    ],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for QuickVue Influenza A+B rapid lateral-flow immunoassay for qualitative detection of influenza type A and B antigens.",
    "Indications for Use Summary": "Aids in rapid differential diagnosis of acute influenza type A and B infections using nasal or nasopharyngeal swab, aspirate, or wash specimens; not intended for influenza C detection or as sole basis for treatment decisions.",
    "fda_folder": "Microbiology"
}